ASH 2020 | Data on Real World Evidence (RWE) on AL amyloidosisAL amyloidosis, Conferences10 December 2020
MPE webinar on ASH 2020 myeloma and AL amyloidosis highlightsAL amyloidosis, MPE, Myeloma8 December 2020
ASH 2020 | Certain people with blood cancers and COVID-19 infection vulnerable to severe illnessAL amyloidosis, Conferences, Myeloma6 December 2020
ASCO and EHA highlights in myeloma and AL amyloidosisAL amyloidosis, Conferences, MPE, Myeloma, Videos20 July 2020
EHA 2020 – Subcutaneous daratumumab shows improved clinical outcomes in AL amyloidosisAL amyloidosis14 June 2020
MPE webinar on the impact of myeloma and AL amyloidosis in carers. What are the issues and challenges?AL amyloidosis, MPE, Myeloma8 May 2020
MPE webinar on personalised medicines in myeloma and AL amyloidosisAL amyloidosis, MPE, Myeloma28 April 2020
